Abstract
Blood coagulation is a complex and tightly regulated physiological network of interacting proteins, cells, and cofactors with multiple amplification and control pathways. The system represents a delicate balance between pro- and anticoagulant and pro- and antifibrinolytic activities. Out of balance, clinically relevant phenotypes (i.e., bleeding and thrombosis) occur and may dramatically influence patients’ outcome.
Current coagulation management and transfusion strategies are based on understanding of the coagulation physiology and specific diagnostic tools. Point-of-care (POC) coagulation monitoring helps to reliably and readily identify the underlying coagulation disorder. With this information, patients can be treated according to their individual needs following goal-directed and clearly defined algorithms.
There are several POC methods available to analyze blood coagulation. According to their main objective and function, POC coagulation analyzers can be categorized into devices focusing on the analysis of primary (cellular), secondary (plasmatic), or the entire hemostasis, from initial thrombin generation to maximum clot formation up to fibrinolysis.
This chapter presents currently available POC coagulation analyzers, discusses their indications and limitations, and shows how POC coagulation monitoring may contribute to improved clinical outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting. Science. 1964;145:1310–2.
Hoffman M, Monroe 3rd DM. A cell-based model of hemostasis. Thromb Haemost. 2001;85(6):958–65.
Ganter MT, Spahn DR. Active, personalized, and balanced coagulation management saves lives in patients with massive bleeding. Anesthesiology. 2010;113(5):1016–8.
Spahn DR, Ganter MT. Towards early individual goal-directed coagulation management in trauma patients. Br J Anaesth. 2010;105(2):103–5.
Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg. 2008;106(5):1366–75.
Hofer CK, Zollinger A, Ganter MT. Perioperative assessment of platelet function in patients under antiplatelet therapy. Expert Rev Med Devices. 2010;7(5):625–37.
Jennings LK. Role of platelets in atherothrombosis. Am J Cardiol. 2009;103(3 Suppl):4A–10.
Gorog DA, Fuster V. Platelet function tests in clinical cardiology: unfulfilled expectations. J Am Coll Cardiol. 2013;61(21):2115–29.
Rubak P, Villadsen K, Hvas AM. Reference intervals for platelet aggregation assessed by multiple electrode platelet aggregometry. Thromb Res. 2012;130(3):420–3.
van Werkum JW, Harmsze AM, Elsenberg EH, Bouman HJ, ten Berg JM, Hackeng CM. The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence. Platelets. 2008;19(7):479–88.
Favaloro EJ. Clinical utility of the PFA-100. Semin Thromb Hemost. 2008;34(8):709–33.
Michelson AD. Methods for the measurement of platelet function. Am J Cardiol. 2009;103(3 Suppl):20A–6.
Shore-Lesserson L. Monitoring anticoagulation and hemostasis in cardiac surgery. Anesthesiol Clin North America. 2003;21(3):511–26.
Thenappan T, Swamy R, Shah A, Nathan S, Nichols J, Bond L, et al. Interchangeability of activated clotting time values across different point-of-care systems. Am J Cardiol. 2012;109(9):1379–82.
Ganter MT, Monn A, Tavakoli R, Genoni M, Klaghofer R, Furrer L, et al. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot. Eur J Cardiothorac Surg. 2006;30(2):278–84.
Noui N, Zogheib E, Walczak K, Werbrouck A, Amar AB, Dupont H, et al. Anticoagulation monitoring during extracorporeal circulation with the Hepcon/HMS device. Perfusion. 2012;27(3):214–20.
Health Quality Ontario. Point-of-Care International Normalized Ratio (INR) monitoring devices for patients on long-term oral anticoagulation therapy: an evidence-based analysis. Ont Health Technol Assess Ser. 2009;9(12):1–114.
Hartert H [not available]. Klinische Wochenschrift. 1948;26(37-38):577–83.
Nielsen VG. A comparison of the Thrombelastograph and the ROTEM. Blood Coagul Fibrinolysis. 2007;18(3):247–52.
Hagemo JS, Naess PA, Johansson P, Windelov NA, Cohen MJ, Roislien J, et al. Evaluation of TEG((R)) and RoTEM((R)) inter-changeability in trauma patients. Injury. 2013;44(5):600–5.
Solomon C, Sorensen B, Hochleitner G, Kashuk J, Ranucci M, Schochl H. Comparison of whole blood fibrin-based clot tests in thrombelastography and thromboelastometry. Anesth Analg. 2012;114(4):721–30.
Haas T, Spielmann N, Mauch J, Madjdpour C, Speer O, Schmugge M, et al. Comparison of thromboelastometry (ROTEM(R)) with standard plasmatic coagulation testing in paediatric surgery. Br J Anaesth. 2012;108(1):36–41.
Brenni M, Worn M, Bruesch M, Spahn DR, Ganter MT. Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy. Acta Anaesthesiol Scand. 2010;54(1):111–7.
von Kaulla KN, Ostendorf P, von Kaulla E. The impedance machine: a new bedside coagulation recording device. J Med. 1975;6(1):73–88.
Hett DA, Walker D, Pilkington SN, Smith DC. Sonoclot analysis. Br J Anaesth. 1995;75(6):771–6.
Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg. 1995;81(2):360–5.
Levy JH, Szlam F, Tanaka KA, Sniecienski RM. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg. 2012;114(2):261–74.
Spahn DR. Severe bleeding in surgical and trauma patients: the role of fibrinogen replacement therapy. Thromb Res. 2012;130 Suppl 2:S15–9.
Spahn DR, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care. 2013;17(2):R76.
Meybohm P, Zacharowski K, Weber CF. Point-of-care coagulation management in intensive care medicine. Crit Care. 2013;17(2):218.
Korte WF. XIII in perioperative coagulation management. Best Pract Res Clin Anaesthesiol. 2010;24(1):85–93.
Levi M, Fries D, Gombotz H, van der Linden P, Nascimento B, Callum JL, et al. Prevention and treatment of coagulopathy in patients receiving massive transfusions. Vox Sang. 2011;101(2):154–74.
Gorlinger K, Dirkmann D, Hanke AA. Potential value of transfusion protocols in cardiac surgery. Curr Opin Anaesthesiol. 2013;26(2):230–43.
Weber CF, Gorlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology. 2012;117(3):531–47.
Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, et al. 2011 Update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91(3):944–82.
Theusinger OM, Spahn DR, Ganter MT. Transfusion in trauma: why and how should we change our current practice? Curr Opin Anaesthesiol. 2009;22(2):305–12.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ganter, M.T., Hofer, C.K. (2014). Point-of-Care Coagulation Monitoring. In: Ehrenfeld, J., Cannesson, M. (eds) Monitoring Technologies in Acute Care Environments. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8557-5_40
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8557-5_40
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8556-8
Online ISBN: 978-1-4614-8557-5
eBook Packages: MedicineMedicine (R0)